Skip to main content

Published locations for 5- and 10-day decitabine go head-to-head in poor-risk AML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. 5- and 10-day decitabine go head-to-head in poor-risk AML

User login

  • Reset your password
  • /content/5-and-10-day-decitabine-go-head-head-poor-risk-aml
  • /hematologynews/article/163718/aml/5-and-10-day-decitabine-go-head-head-poor-risk-aml
  • /oncologypractice/article/163718/aml/5-and-10-day-decitabine-go-head-head-poor-risk-aml
  • /hematology-oncology/article/163718/aml/5-and-10-day-decitabine-go-head-head-poor-risk-aml